• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

How RFK Jr. might in­flu­ence the FDA; Phar­ma's Q3 high­lights; Ab­b­Vie's lat­est neu­ro buy­out; and more

7 months ago
Weekly

BMS, J&J and As­traZeneca plea with ap­peals court to over­turn drug price ne­go­ti­a­tions

7 months ago
Pharma
Law

Ex­clu­sive: Women’s health uni­corn Maven Clin­ic cuts 10% of its work­force weeks af­ter rais­ing $125M

7 months ago
People
Health Tech

Her­itage and Apo­tex to pay $49.1M in price-fix­ing set­tle­ment

7 months ago
Pharma
Law

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

7 months ago
R&D

FDA re­moves hold on three CARs­gen CAR-T tri­als; Ono pass­es on itolizum­ab

7 months ago
News Briefing

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

7 months ago
Financing
Cell/Gene Tx

Bax­ter pulls IV prod­ucts out of Chi­na to shift sup­ply to the US

7 months ago
China
Manufacturing

Es­sa’s shares tank as it looks for op­tions af­ter aban­don­ing prostate can­cer drug

7 months ago
R&D

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

7 months ago
Peer Review

Q&A with Obe­si­ty So­ci­ety’s CEO as the field pre­pares for next-gen meds

7 months ago
Pharma

Fol­low­ing 2019 re­jec­tion, FDA ad­comm votes against Lex­i­con's type 1 di­a­betes and CKD drug

7 months ago
FDA+

Te­va fined €462.6M by Eu­ro­pean reg­u­la­tors over Co­pax­one patent and com­pe­ti­tion al­le­ga­tions

7 months ago
Pharma
Law

UCB's an­ti-tau Alzheimer's pro­gram fails Phase 2 pri­ma­ry end­point, but high­lights pos­i­tive sec­on­daries

7 months ago
R&D

Fed­er­al court backs FDA's ap­proval of com­peti­tor to Jaz­z's sleep drug

7 months ago
Pharma
FDA+

‘Im­i­ta­tion is best form of flat­tery’: Re­gen­eron CEO com­ments on Am­gen’s Eylea biosim­i­lar

7 months ago
R&D
Pharma

Q&A: Jade CEO talks about re­verse merg­er and IgAN drugs

7 months ago
Startups
Deals

Gar­dasil de­mand in Chi­na sinks, and Mer­ck ex­pects the same next quar­ter

7 months ago
China
Pharma

WuXi in ‘ear­ly stages’ of CGT busi­ness re­view; Lon­za ex­ec be­comes AGC Bio CEO

7 months ago
Manufacturing

Take­da says mul­ti­year re­struc­tur­ing is 'on track'

7 months ago
R&D
Pharma

Ar­genx re­ports Vyv­gart sales streak, bol­stered by launch in rare neu­ro dis­or­der

7 months ago
Pharma

Boehringer, Gubra stop work on obe­si­ty drug; Gala­pa­gos restarts CAR-T study

7 months ago
News Briefing

Why a promi­nent health tech VC keeps ad­just­ing how it thinks about AI in health­care

7 months ago
AI
Health Tech

Evom­mune rais­es $115M for I&I pipeline and pre­pares for Phase 2 re­sults

7 months ago
Financing
Startups
First page Previous page 82838485868788 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times